News | SK Capital

All News

Genetix

bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots

September 18, 2025

J&K Ingredients

J&K Ingredients Makes Strategic IP Acquisition from NuTek Natural Ingredients, Strengthening Technical Leadership in Clean-Label Solutions

August 19, 2025

Acquisitions

SK Capital has entered into exclusive negotiations to acquire LISI Group’s Medical division

July 9, 2025

Acquisitions

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

June 2, 2025

Uncategorized

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

May 30, 2025

Uncategorized

Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions

May 16, 2025

Load More